Oxidation state of graphene oxide nanosheets drives their interaction with proteins: A case of bovine serum albumin

Ekal, Neha  S.; Patil, Rahul; Ranjan, Nihar; Bahadur, Pratap; Tiwari, Sanjay

doi:10.1016/j.colsurfb.2022.112367

Cited by 7 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Conjugation of GO with BSA protein and FITC fluorophore produced better dispersibility in working medium (RPMI) of GO and enabled us to monitor cellular uptake and reduce nanosheet thickness. In addition to the morphological-topographic result, obtained by AFM, the decrease in fluorescence due to quenching confirmed the formation of a stable composite GO-BSA-FITC; it was known GO nanosheets had a great adsorption capacity for proteins like BSA [36] and functionalization with serum proteins improved uptake and biocompatibility [37].…”

Section: Discussionmentioning

confidence: 71%

Biological Effects of Small Sized Graphene Oxide Nanosheets on Human Leukocytes

Aventaggiato,

Valentini,

Caissutti

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Since the discovery of graphene, there has been a wide range of the literature dealing with its versatile structure and easy binding of biomolecules as well as its large loading capacity. In the emerging field of immunotherapy, graphene and its derivatives have potential uses as drug delivery platforms directly into tumour sites or as adjuvants in cancer vaccines, as they are internalized by monocytes which in turn may activate adaptive anti-tumoral immune responses. In this study, we expose cells of the innate immune system and a human acute monocytic leukemia cell line (THP-1) to low doses of small-sized GO nanosheets functionalized with bovine serum albumin (BSA) and fluorescein isothiocyanate (FITC), to study their acute response after internalization. We show by flow cytometry, uptake in cells of GO-BSA-FITC reaches 80% and cell viability and ROS production are both unaffected by exposure to nanoparticles. On the contrary, GO-BSA nanosheets seem to have an inhibitory effect on ROS production, probably due to their antioxidant properties. We also provided results on chemotaxis of macrophages derived from peripheral blood monocytes treated with GO-BSA. In conclusion, we showed the size of nanosheets, the concentration used and the degree of functionalization were important factors for biocompatibility of GO in immune cells. Its low cytotoxicity and high adaptability to the cells of the innate immune system make it a good candidate for deployment in immunotherapy, in particular for delivering protein antigens to monocytes which activate adaptive immunity.

show abstract

Section: Discussionmentioning

confidence: 71%